Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors

摘要

The present invention relates generally to a novel class of imidazolidinones of Formula (I): that are useful as serine protease inhibitors, and more particularly as Hepatitis C virus NS3 protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.